Home > Healthcare > Medical Services > Assisted Reproductive Technology (ART) Market

Assisted Reproductive Technology (ART) Market Trends

  • Report ID: GMI506
  • Published Date: May 2024
  • Report Format: PDF

Assisted Reproductive Technology Market Trends

With the evolution of societal attitudes and the growing acceptance of ART, there is a rising trend among individuals and couples to utilize these advanced reproductive technologies to surmount infertility challenges and achieve their aspirations of parenthood.

  • Over time, societal norms and values regarding family formation, parenthood, and reproductive options have evolved. There is greater acceptance and recognition of diverse family structures, including single-parent families, same-sex couples, and individuals pursuing parenthood independently.
  • For instance, according to the Department of Health, State Government of Victoria, Australia, in 2024, single-male-parent families are the fastest growing family, increasing between 44% to 65% by 2041. As per the same report, single-female-parent families are projected to make up 13% to 14% of all families in 2041.
  • Further as per the recent statistics, in the 1950s, less than 10% of families with children were single parent, whereas in 2022, among families with children, 31% were single-parent — more than three times as common.
  • Increased cultural and religious acceptance of ART, coupled with a desire to adhere to cultural and religious values while addressing infertility, and utilizing fertility testing devices, leading to greater utilization of ART services among diverse populations, thereby stimulating the growth of the market.
Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Assisted reproductive technology market size was USD 34.7 billion in 2023 and is expected to register 6.9% CAGR from 2024-2032 owing to the rising prevalence of infertility across the population base worldwide.

Assisted reproductive technology industry from the procedure segment is expected to reach USD 58.6 billion by 2032 due to rising prevalence of infertility owing to various factors such as lifestyle changes, environmental factors, and delaying childbirth.

The U.S. assisted reproductive technology industry is expected to register 6.5% CAGR from 2024-2032 due to the increasing percentage of IVF delivery rate/cycle and rising number of patients adopting the ART procedures in the region.

Merck KGaA, MISTRAL FERTILITY CLINICS S.L., NidaCon International AB, Sumitomo Mitsui Financial Group, Inc., The Cooper Companies, Inc., Thermo Fisher Scientific Inc., Vitrolife Group, and Western Fertility Institute, are some of the major assisted reproductive technology companies worldwide.

Assisted Reproductive Technology Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2023
  • Companies covered: 16
  • Tables & Figures: 196
  • Countries covered: 19
  • Pages: 125
 Download Free Sample